Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03668002 · ClinicalTrials.gov registry record · NA
Trial of Fistula Versus Graft in Elderly Patients
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03668002 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 21 participants.
The verdict
NCT03668002, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This open-label pilot randomized controlled trial will test the feasibility and safety of randomizing patients over 65 years old who start hemodialysis with a tunneled dialysis catheter (TDC), and are eligible to receive either arteriovenous fistula (AVF) or arteriovenous graft (AVG), to an AVF strategy (comparator) or to an AVG strategy (intervention). The primary outcome is feasibility, which we will assess by measuring: (1) the proportion of randomized participants who receive the assigned arteriovenous access; and (2) the annual rate of enrollment in the study, accounting for the number of surgeons who participate. Secondary outcomes will include perioperative morbidity and mortality, catheter removal rates, additional procedures performed, and the reasons a patient may not receive the assigned AV access.
Interventions
- PROCEDURE Arteriovenous Fistula (AVF)
- PROCEDURE Arteriovenous Graft (AVG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2023-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03668002
The ClinicalTrials.gov registry entry for NCT03668002 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arteriovenous Fistula (AVF) is the first listed.
NCT03668002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03668002 about?
NCT03668002 is a clinical study titled "Trial of Fistula Versus Graft in Elderly Patients". This open-label pilot randomized controlled trial will test the feasibility and safety of randomizing patients over 65 years old who start hemodialysis with a tunneled dialysis catheter (TDC), and are eligible to receive either arteriovenous fistula (AVF) or arteriovenous graft (AVG), to an AVF stra...
What is the current status of trial NCT03668002?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2018-09-14. Estimated completion is 2023-08-07.
What interventions are being tested in trial NCT03668002?
The interventions under investigation include: Arteriovenous Fistula (AVF) (PROCEDURE), Arteriovenous Graft (AVG) (PROCEDURE).
Who is sponsoring clinical trial NCT03668002?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.